300 related articles for article (PubMed ID: 35504760)
21. Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines.
Lai Y; Asthana A; Kisaalita WS
Drug Discov Today; 2011 Apr; 16(7-8):293-7. PubMed ID: 21277382
[TBL] [Abstract][Full Text] [Related]
22. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
23. Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges.
Montanez-Sauri SI; Beebe DJ; Sung KE
Cell Mol Life Sci; 2015 Jan; 72(2):237-49. PubMed ID: 25274061
[TBL] [Abstract][Full Text] [Related]
24. Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review.
Biju TS; Priya VV; Francis AP
Drug Deliv Transl Res; 2023 Sep; 13(9):2239-2253. PubMed ID: 36971997
[TBL] [Abstract][Full Text] [Related]
25. Microfluidic cell chips for high-throughput drug screening.
Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
[TBL] [Abstract][Full Text] [Related]
26. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
[TBL] [Abstract][Full Text] [Related]
27. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
[TBL] [Abstract][Full Text] [Related]
28. 3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons.
Tong ZB; Huang R; Braisted J; Chu PH; Simeonov A; Gerhold DL
SLAS Discov; 2024 Apr; 29(3):100143. PubMed ID: 38280460
[TBL] [Abstract][Full Text] [Related]
29. Three-Dimensional Cell Cultures in Drug Discovery and Development.
Fang Y; Eglen RM
SLAS Discov; 2017 Jun; 22(5):456-472. PubMed ID: 28520521
[TBL] [Abstract][Full Text] [Related]
30. 3D in vitro tissue models and their potential for drug screening.
Kimlin L; Kassis J; Virador V
Expert Opin Drug Discov; 2013 Dec; 8(12):1455-66. PubMed ID: 24144315
[TBL] [Abstract][Full Text] [Related]
31. Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture.
Worthington P; Drake KM; Li Z; Napper AD; Pochan DJ; Langhans SA
Anal Biochem; 2017 Oct; 535():25-34. PubMed ID: 28757092
[TBL] [Abstract][Full Text] [Related]
32. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
33. Current progress in high-throughput screening for drug repurposing.
Khambhati K; Siruka D; Ramakrishna S; Singh V
Prog Mol Biol Transl Sci; 2024; 205():247-257. PubMed ID: 38789182
[TBL] [Abstract][Full Text] [Related]
34. Development of a novel high-throughput culture system for hypoxic 3D hydrogel cell culture.
Egger D; Baier L; Moldaschl J; Taschner M; Lorber V; Kasper C
Sci Rep; 2024 Apr; 14(1):9904. PubMed ID: 38688981
[TBL] [Abstract][Full Text] [Related]
35. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
Burkhart RA; Baker LA; Tiriac H
Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
[TBL] [Abstract][Full Text] [Related]
36. Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.
Li X; Zhang X; Zhao S; Wang J; Liu G; Du Y
Lab Chip; 2014 Feb; 14(3):471-81. PubMed ID: 24287736
[TBL] [Abstract][Full Text] [Related]
37. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
Struzyna LA; Watt ML
Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
[TBL] [Abstract][Full Text] [Related]
38. Application of In Vitro Metabolism Activation in High-Throughput Screening.
Ooka M; Lynch C; Xia M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142951
[TBL] [Abstract][Full Text] [Related]
39. Microarray Embedding/Sectioning for Parallel Analysis of 3D Cell Spheroids.
Gabriel J; Brennan D; Elisseeff JH; Beachley V
Sci Rep; 2019 Nov; 9(1):16287. PubMed ID: 31705048
[TBL] [Abstract][Full Text] [Related]
40. Advances in microfluidic 3D cell culture for preclinical drug development.
Russo M; Cejas CM; Pitingolo G
Prog Mol Biol Transl Sci; 2022; 187(1):163-204. PubMed ID: 35094774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
